Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $23.00 price target on the stock.
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]